News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,947 Results
Type
Article (13838)
Company Profile (101)
Press Release (253008)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88148)
Career Advice (465)
Deals (15358)
Drug Delivery (67)
Drug Development (36622)
Employer Resources (49)
FDA (6337)
Job Trends (6205)
News (150421)
Policy (14085)
Tag
Academia (442)
Accelerated approval (2)
Adcomms (6)
Allergies (38)
Alliances (23252)
ALS (39)
Alzheimer's disease (394)
Antibody-drug conjugate (ADC) (46)
Approvals (6375)
Artificial intelligence (115)
Autoimmune disease (9)
Automation (4)
Bankruptcy (149)
Best Places to Work (4371)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (22)
Brain cancer (16)
Breast cancer (83)
Cancer (654)
Cardiovascular disease (74)
Career advice (409)
Career pathing (12)
CAR-T (23)
Cell therapy (92)
Cervical cancer (5)
Clinical research (30987)
Collaboration (362)
Compensation (166)
Complete response letters (17)
COVID-19 (760)
CRISPR (23)
C-suite (133)
Cystic fibrosis (39)
Data (697)
Denatured (15)
Depression (10)
Diabetes (85)
Diagnostics (1331)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (67)
Drug shortages (12)
Duchenne muscular dystrophy (39)
Earnings (32407)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (37718)
Executive appointments (406)
FDA (6821)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (221)
Gene editing (41)
Generative AI (9)
Gene therapy (103)
GLP-1 (351)
Government (1310)
Grass and pollen (3)
Guidances (61)
Healthcare (3571)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (37)
Indications (14)
Infectious disease (796)
Inflammatory bowel disease (58)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (48)
Interviews (59)
IPO (5893)
IRA (29)
Job creations (2053)
Job search strategy (373)
Kidney cancer (6)
Labor market (13)
Layoffs (182)
Leadership (4)
Legal (3441)
Liver cancer (19)
Lung cancer (88)
Lymphoma (57)
Machine learning (4)
Management (16)
Manufacturing (172)
MASH (34)
Medical device (1330)
Medtech (1332)
Mergers & acquisitions (9683)
Metabolic disorders (270)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (25)
Neuropsychiatric disorders (8)
Neuroscience (588)
NextGen: Class of 2025 (1588)
Non-profit (599)
Now hiring (8)
Obesity (153)
Opinion (119)
Ovarian cancer (22)
Pain (58)
Pancreatic cancer (17)
Parkinson's disease (48)
Partnered (7)
Patents (127)
Patient recruitment (31)
Peanut (10)
People (29023)
Pharmaceutical (64)
Pharmacy benefit managers (12)
Phase I (8067)
Phase II (13108)
Phase III (11762)
Pipeline (536)
Policy (74)
Postmarket research (1401)
Preclinical (3238)
Press Release (25)
Prostate cancer (48)
Psychedelics (8)
Radiopharmaceuticals (122)
Rare diseases (175)
Real estate (2638)
Recruiting (17)
Regulatory (10180)
Reports (16)
Research institute (566)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (38)
Series A (39)
Series B (15)
Service/supplier (3)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1632)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (36)
The Weekly (30)
Vaccines (160)
Venture capitalists (14)
Weight loss (100)
Women's health (8)
Worklife (4)
Date
Today (53)
Last 7 days (338)
Last 30 days (1053)
Last 365 days (11750)
2025 (4277)
2024 (12567)
2023 (14253)
2022 (19607)
2021 (20144)
2020 (19088)
2019 (14930)
2018 (11727)
2017 (13904)
2016 (13135)
2015 (15487)
2014 (12439)
2013 (10602)
2012 (11417)
2011 (11943)
2010 (10900)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (58)
Arkansas (3)
Asia (20173)
Australia (2622)
California (1855)
Canada (955)
China (255)
Colorado (72)
Connecticut (73)
Delaware (62)
Europe (39592)
Florida (356)
Georgia (40)
Idaho (9)
Illinois (206)
India (16)
Indiana (138)
Iowa (1)
Japan (101)
Kansas (60)
Kentucky (13)
Louisiana (2)
Maine (2)
Maryland (273)
Massachusetts (1601)
Michigan (30)
Minnesota (99)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (9)
New Hampshire (6)
New Jersey (812)
New Mexico (7)
New York (547)
North Carolina (409)
North Dakota (2)
Northern California (771)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (476)
Puerto Rico (8)
Rhode Island (10)
South America (503)
South Carolina (3)
Southern California (777)
Tennessee (36)
Texas (247)
United States (7719)
Utah (37)
Virginia (81)
Washington D.C. (32)
Washington State (127)
Wisconsin (19)
266,947 Results for "impel pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharyngitis Market Size to Reach USD 2.5 Billion by 2035, Impelled by Escalating Incidence of Pharyngitis
February 19, 2025
·
5 min read
Press Releases
Whim Syndrome Market Size to Reach USD 15.2 Million by 2035, Impelled by Technological Advancements
February 13, 2025
·
7 min read
Press Releases
Polycythemia Vera Market Size to Reach USD 79.0 Billion by 2035, Impelled by Advancements in Targeted Therapies.
February 11, 2025
·
11 min read
Press Releases
Panuveitis Market Expected to Grow at a CAGR Of 7.55% During 2025-2035, impelled by Advancements in Innovative Therapies
February 7, 2025
·
10 min read
BioForest
Impel Pharmaceuticals Announces Exploration of Strategic Alternatives
Impel Pharmaceuticals Inc. today announced that it has initiated an exploration of strategic alternatives.
October 5, 2023
·
3 min read
Press Releases
Sciatica Market Size to Reach USD 3.4 Billion by 2035, Impelled by Advancements in Regenerative Therapies
February 19, 2025
·
9 min read
Press Releases
Myocarditis Market Size to Reach USD 2,391.5 Million by 2035, Impelled by Rising Incidence of Myocarditis
February 19, 2025
·
7 min read
Press Releases
Cardiotoxicity Market Size to Reach USD 948.63 Million by 2035, Impelled by Surge in Heart Disease Incidents
February 14, 2025
·
7 min read
Press Releases
Vertigo Market Size to Reach USD 2.1 Billion by 2035, Impelled by Advancements in Diagnostic Technologies
February 13, 2025
·
8 min read
Press Releases
Status Epilepticus Market Size to Reach USD 1,338 Million by 2035, Impelled by Escalating Prevalence of Epilepsy
February 11, 2025
·
9 min read
1 of 26,695
Next
